Divyaswathi Citla Sridhar: We Counsel Patients With Obesity About VTE Risk, But What Does Real-World Data Actually Show?
Divyaswathi Citla Sridhar, a pediatric hematologist and oncologist at Arkansas Children’s Hospital, shared a post on LinkedIn:
“We counsel patients with obesity about VTE risk—but what does real-world data actually show?
Our new study published in RPTH Journal analyzed >4 million females prescribed hormonal therapy and found:
• Higher VTE rates with several ethinyl-estradiol–containing therapies in obese users
• No significant VTE increase with progesterone-only therapy
Title: Venous thromboembolism in obese hormonal contraceptive users: a large national database study
Authors: Divyaswathi Citla-Sridhar, Madhvi Rajpurkar, Lakshmi Srivaths, Bethany Samuelson Bannow, Rachel P. Rosovsky, Nancy Sokkary.
Grateful to work with a fantastic group of collaborators: Madhvi Rajpurkar Lakshmi Srivaths Bethany Samuelson Bannow Rachel Rosovsky Nancy Sokkary & Foundation for Women & Girls With Blood Disorders.”
Learn more with Hemostasis Today.
-
Mar 13, 2026, 22:57Robert Hamilton: The Reality of Stroke Care and Why 81.6% Should be a Wake-Up call
-
Mar 13, 2026, 22:05Christoph B. Olivier: Annabel Hölzle Shared Critical Findings on HALT After TAVR
-
Mar 13, 2026, 21:29Timothy Glidewell: Genetic Signals of Platelet and Clotting Pathways in Cryptogenic Stroke
-
Mar 13, 2026, 21:19New Canadian Insights on Switching to Longer-Acting Therapy for Hemophilia A – WFH
-
Mar 13, 2026, 21:01Leonardo Roever: Brain Age as a Biomarker of Neuroplasticity and Motor Recovery After Stroke
-
Mar 13, 2026, 20:50William Tembo: Understanding Stroke Through Landmark Clinical Trials
-
Mar 13, 2026, 20:35Jessica Garcia: New Evidence on Thrombin Generation Patterns in Children with Hemophilia A
-
Mar 13, 2026, 20:11Christoph B. Olivier: New Research from Marius Wessinger on Predicting Therapy Success After Pulmonary Embolism
-
Mar 13, 2026, 19:53Wolfgang Miesbach Announces the New English Edition of “Gene Therapy Concepts in the Treatment of Haemophilia”